Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 4 1Phase 3 1

Status

Recruiting 4Active not recruiting 2

Sponsor Class

INDUSTRY 6OTHER 2NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Myeloid 6Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 200Neoplasms 116Breast Neoplasms 112Colorectal Neoplasms 97Ovarian Neoplasms 78Prostatic Neoplasms 75Neoplasm Metastasis 74Lung Neoplasms 66Multiple Myeloma 64Squamous Cell Carcinoma of Head and Neck 49Pancreatic Neoplasms 48Endometrial Neoplasms 48Recurrence 46Stomach Neoplasms 39Carcinoma, Renal Cell 39Small Cell Lung Carcinoma 38Melanoma 38Leukemia, Lymphocytic, Chronic, B-Cell 38Leukemia, Myeloid, Acute 34Lymphoma, Non-Hodgkin 30Urinary Bladder Neoplasms 29Parkinson Disease 4, Autosomal Dominant Lewy Body 29Triple Negative Breast Neoplasms 28Head and Neck Neoplasms 26Carcinoma, Hepatocellular 26Lymphoma, Large B-Cell, Diffuse 25Lymphoma, Follicular 25Esophageal Neoplasms 24Advanced Solid Tumors 24Lymphoma 23

Interventions

ruxolitinib 1Panobinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Polycythemia Vera × 30 days × Clear all
NCT07429266 2026-06-05

INTREPID

Ono Pharmaceutical Co., Ltd.

Phase 3 Recruiting
250 enrolled
Myeloid

Polycythemia Vera

NCT05143957 2026-06-01

A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera

Ionis Pharmaceuticals, Inc.

Phase 2 Active not recruiting
50 enrolled
Myeloid

Polycythemia Vera

NCT07441694 2026-05-29

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Incyte Corporation

Phase 1 Recruiting
218 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT07469891 2026-05-29

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Prelude Therapeutics

Phase 1 Recruiting
100 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Primary Myelofibrosis

NCT06985147 2026-05-28

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

Disc Medicine, Inc

Phase 2 Recruiting
60 enrolled
Myeloid

Polycythemia Vera

NCT02386800 2026-05-27

CINC424A2X01B Rollover Protocol

Novartis

Phase 4 Active not recruiting
279 enrolled
MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Polycythemia Vera, Thalassemia, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡